Classification (1) Classification (3) Classification (2) Spindle cell lesions. Spindle cell lesions of bladder (Mills et al.

Similar documents
Spindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Newer soft tissue entities

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD

Inflammatory Myofibroblastic Tumor of the Bladder

Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology

57th Annual HSCP Spring Symposium 4/16/2016

Condyloma Acuminatum. Mimics of Bladder Cancer. Squamous Papilloma. Squamous epithelium in bladder

An Overview of Genital Stromal Tumors

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

Enterprise Interest Nothing to declare

ACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.

A 25 year old female with a palpable mass in the right lower quadrant of her abdomen

05/07/2018. Types of challenges. Challenging cases in uterine pathology. Case 1 ` 65 year old female Post menopausal bleeding Uterine Polyp

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Lung Tumor Cases: Common Problems and Helpful Hints

Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Financial disclosures

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

No financial or other disclosures

Gastrointestinal stromal tumor

Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

GUT-C 11/30/2017. Debasmita Das, M.D. PGY-1 Danbury Hospital

Diagnostic Value of Immunohistochemistry in Soft Tissue Tumors

I have nothing to disclose

Diagnostic problems in uterine smooth muscle tumors

5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani

Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia

CASE year old male with a PET avid nodule in the left adrenal gland

Brief History. Identification : Past History : HTN without regular treatment.

Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia

TitleSarcomatoid carcinoma of the bladde.

Special slide seminar

59 yo male with past medical history of prostate carcinoma, presented with upper abdominal pain

21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells

Inflammatory Myofibroblastic Tumor of the Bladder:

PROBLEMS OF PROGNOSTICATION IN SOFT TISSUE TUMOURS. Christopher D.M. Fletcher Brigham and Women s Hospital and Harvard Medical School Boston, MA

Keywords solitary fibrous tumor, dedifferentiation, dedifferentiated solitary fibrous tumor, STAT6, GRIA2, cytokeratin, rhabdomyosarcomatous

Malignant Peripheral Nerve Sheath Tumor

SOFT TISSUE TUMOR PATHOLOGY: AN UPDATE

Case: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT

Aspen conference on pediatric disease. July through August Bone and Soft Tissue Update. David M. Parham, MD. Rhabdomyoma and rhabdomyosarcoma

3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships

Spectrum of Lesions in Cystoscopic Bladder Biopsies -A Histopathological Study

IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF SOFT TISSUE TUMORS

History A 89 year old gentleman presenting with a scalp/forehead nodule. Patient had squamous cell carcinoma 18 m at same site, excised. Outside diagn

Financial disclosures

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Notice of Faculty Disclosure

What really matters When and Why. Pathology of Uterine Mesenchymal Lesions. Nafisa Wilkinson London

Pathology Mystery and Surprise

Unusual Variants of Bladder Cancer Cristina Magi-Galluzzi, MD, PhD

3/27/2017. Disclosure of Relevant Financial Relationships

Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016

Part 1. Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013

CASE REPORT Benign epithelioid peripheral nerve sheath tumour resembling schwannoma

Cerebral Parenchymal Lesions: I. Metastatic Neoplasms

Normal endometrium: A, proliferative. B, secretory.

Disclosure. Case. Mixed Tumors of the Uterine Corpus and Cervix. I have nothing to disclose

Case: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on

Case 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset

SMOOTH MUSCLE TUMOURS

Case Report Inflammatory Myofibroblastic Tumor of the Nasal Septum

Endometrial Stromal Tumors

The role of immunohistochemistry in surgical pathology of the uterine corpus and cervix

Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report

Case E1. Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour

Biopsy Interpretation of Spindle cell proliferations of the Serosa

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Prostatic stromal hyperplasia with atypia (PSHA) is a

Case Presentation. Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD. Department of Pathology Jordan University Hospital Amman, Jordan

Division of Pathology

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

ESS: Pathologic Insights

When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?

American Journals of Cancer Case Reports. A Rare Case of Rectal Metastasis from Sarcomatoid Variant of Urothelial Carcinoma: A Case Report

Interesting Cases in Gynecologic Pathology. Michael Ward, MD Surgical Pathology Fellow University of Utah Health Sciences Center Salt Lake City, UT

EQA Circulation 43 Educational Cases

Accepted Manuscript. Low grade spindle cell sarcoma of the true vocal folds. Samuel R. Barber, Pavel Kopach, Elizabeth M. Genega, Thomas L.

Inflammatory pseudotumor

Low-Grade Periductal Stromal of Breast: a case report

Sarcomatoid Carcinoma of the Urinary Bladder: A Clinicopathological Study of 4 Cases and a Review of the Literature

Review of the AP Part II Practical Examination. Dr David Clift Co Chief Examiner

Small (and large) Blue Cell Tumors of the Skull Base

DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology

USCAP 2011: ASDP companion meeting. Steven D. Billings 1

Case 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Among the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews

EDUCATIONAL CASES E1 & E2. Natasha Inglis 20/03/15

Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Transcription:

Non-epithelial tumours and nonepithelial tumour-like lesions of the bladder Dr Jonathan H Shanks The Christie NHS Foundation Trust, Manchester, UK Classification (1) Myofibroblastic proliferations and neoplasms Inflammatory myofibroblastic tumour/pseudosarcomatous myofibroblastic proliferation Postoperative spindle cell nodule Benign soft tissue tumours Leiomyoma Haemangioma Neurofibroma Schwannoma Solitary fibrous tumour Paraganglioma Granular cell tumour Classification (2) Malignant soft tissue tumours Leiomyosarcoma Rhabdomyosarcoma Angiosarcoma MFH PNET MPNST Alveolar soft part sarcoma Classification (3) Other tumours Lymphoma and other haemolymphoid lesions Malignant melanoma Other tumour-like conditions Malakoplakia Amyloid Spindle cell lesions of bladder (Mills et al., 1989) The differential diagnosis of bladder spindle cell lesions is one of the most difficult in surgical pathology and of considerable clinical importance In view of the diagnostic difficulty it is wise to excise any problematic spindle cell bladder lesion, especially if only limited biopsy material is available Inflammatory myofibroblastic tumour [IMT]/pseudosarcomatous myofibroblastic proliferation post-operative spindle cell nodule Spindle cell lesions Sarcomatoid carcinoma/ carcinosarcoma Leiomyosarcoma and other sarcomas Other spindle cell lesions e.g. neurofibroma, leiomyoma, solitary fibrous tumour [although written almost a quarter of a century ago, remains true today!]

Pseudosarcomatous myofibroblastic proliferations of the urinary tract nomenclatures which have been applied to such lesions historically in the literature Nodular fasciitis Pseudomalignant spindle cell proliferation Pseudosarcomatous myofibroblastic tumour Pseudosarcomatous fibromyxoid tumor Inflammatory pseudotumour Current nomenclature Inflammatory myofibroblastic tumour (IMFT/IMT) Pseudosarcomatous myofibroblastic proliferation Post-operative spindle cell nodule [ Inflammatory pseudotumour is generally regarded as an umbrella term] Features of IMT/pseudosarcomatous myofibroblastic proliferation of bladder Often sizeable pedunculated mass (except post-operative spindle cell nodule which is typically small) Often gelatinous/myxoid Frequent involvement of detrusor muscle Features of IMT/pseudosarcomatous myofibroblastic proliferation of bladder 3 histological patterns - myxoid vascular - compact - hypocellular fibrous Minimal to absent nuclear pleomorphism, no nuclear hyperchromasia - can have scattered ganglion-like cells with prominent nucleoli - can have some cells like strap cells (mimic of rhabdomyosarcoma but no cambium layer and myogenin ve) May have mitoses, but no abnormal mitosis Small foci necrosis may be seen but no substantial areas of necrosis Pseudosarcomatous myofibroblastic tumor of the urinary bladder in children (Hojo et al., 1995) Note of caution: similar reaction sometimes seen adjacent to carcinoma (care required in limited biopsies) Can easily be mistaken for embryonal rhabdomyosarcoma, clinically, radiologically and histologically All but 1 [of 11] cases initially diagnosed as sarcoma, usually rhabdomyosarcoma

Inflammatory myofibroblastic tumour/pseudosarcomatous myofibroblastic proliferation of bladder 50% cases ALK-1 protein ve (cytoplasmic) ALK-1 translocation demonstrated in about 50% cases (in some series) gene 2p23 involved Alk-1 expression not described in sarcomatoid carcinoma or leiomyosarcoma of bladder but can be seen in rhabdomyosarcoma Overlap in cytokeratin expression in all of above lesions but high mol. wt. cytokeratins restricted to sarcomatoid carcinoma Anaplastic lymphoma kinase 1 (ALK-1) Useful in distinction of inflammatory myofibroblastic tumour/pseudosarcomatous myofibroblastic proliferation of bladder (ve in fewer than 50% of cases) from other spindle cell lesions of bladder Cytoplasmic staining Expression correlates to some degree with ALK- 1 gene rearrangement Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma (Montgomery EA et al Am J Surg Pathol 2006;30:1502-12) One unique case with features of IMT of bladder with ALK gene rearrangement (but lacking ALK expression by immuno) showed focal overtly sarcomatous areas ( inflammatory fibrosarcoma ). It recurred rapidly and then metastasised causing death. No other case described in the bladder has metastasised (these lesions almost always follow a benign course but may recur and may cause obstructive problems if large). AlK-1 expression in soft tissue lesions: Expression of Alk1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics Cessna MH et al., 2002 Expression of anaplastic lymphoma kinase in soft tissue tumors:an immunohistochemical and molecular study of 249 cases (Li et al., 2004) 14 inflammatory myofibroblastic tumours (IMTs) and 370 other soft tissue tumours studied for Alk-1 expression 8/14 soft tissue IMTs ve 10/38 rhabdomyosarcomas ve 35/65 lipogenic tumours ve 6/10 Ewings/PNET ve 4/10 MPNSTs ve 4/28 leiomyosarcomas ve [1/10 in Cessna paper](but not reported in bladder leiomyosarcoma) Leiomyoma 0/10 9/48 MFH ve Most tumours other than IMT showed low level expression Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder Westfall et al. Am J Surg Pathol 2009;33:99-105 Alk-1 was ve in 20% of 10 pseudosarcomatous myofibroblastic proliferations and was negative in all (n=22) sarcomatoid carcinoma and smooth muscle neoplasms (n=13) CK5/6 and 34BE12 were positive in 27% and 25% sarcomatoid carcinoma but negative in all pseudosarcomatous myofibroblastic proliferations (PMP) and smooth muscle tumours p63 was positive in 50% of sarcomatoid carcinoma and focally in 23% smooth muscle tumours but negative in PMPs Relationship of bladder IMT and IMT of soft tissue? Still controversial and not fully resolved Bladder lesions more likely to express cytokeratins Bladder lesions probably less likely to recur and less likely to metastasise (only 1 reported case), although even in soft tissue cases metastases are rare The single case with metastases in the bladder had prior irradiation?? Could this have been an initiating step in progression to sarcoma

Differential diagnosis of IMT/pseudosarcomatous myofibroblastic proliferation of urinary tract Sarcomatoid carcinoma Leiomyosarcoma Rhabdomyosarcoma Other mesenchymal tumour e.g. solitary fibrous tumour Spindle cell lesions of bladder Good sampling required to look for any areas of carcinoma in situ or conventional invasive carcinoma (features that would support sarcomatoid carcinoma, but may be present only focally) In a child with a myxoid spindle cell lesion in the bladder or urinary tract Myxoid and sclerosing sarcomatoid transitional cell carcinoma: a clinicopathological and immunohistochemical study of 25 cases (Jones and Young, 1997) Need high index of suspicion for rhabdomyosarcoma Embryonal rhabdomyosarcoma may have areas that are relatively bland cytologically Look for cambium layer Include myogenin /- myo D1 in immunohistochemistry panel Rhabdomyosarcoma is positive for alpha smooth muscle actin and may be Alk-1 positive Heterologous cartilage may occasionally be seen in rhabdomyosarcoma Leiomyosarcoma of the urinary bladder (Mills et al., 1989) 15 cases rare tumour but most common bladder sarcoma in adults Wide age range 8 tumours had 1 or <1 MF/10HPF All had infiltrative margins with invasion of detrusor muscle 9 had myxoid zones; 6 were mainly or extensively myxoid (haphazard rather than fascicular orientation of fibres when myxoid) closely resembled IMT, esp. in superficial areas of the tumour 3 cases had necrosis All alpha-sma ve; 8/15 desmin ve; 12/12 cytokeratin and EMA -ve Leiomyosarcoma of the urinary bladder (Mills et al., 1989) Mild to moderate nuclear pleomorphism; marked pleomorphism in 4/15 cases Myxoid cases had some extravasated erythrocytes superficial inflammation (appearance v similar or identical focally to IMT); delicate capillary network typically lacking in most leiomyosarcoma (cf. IMFT) Preferred to designate lesions when infiltrative (even if <1MF/10HPF) as leiomyosarcoma. Mets rare if <5MF/10HPF) Mitotic counts may be underestimated in. myxoid areas due to wide cell separation

Leiomyosarcoma of the urinary bladder: a clinicopathological study of 34 cases Lindberg MR et al. J Clin Pathol 2010;63:708-713 Similarities: bladder spindle cell lesions Essentially all urinary bladder leiomyosarcomas are high-grade sarcomas and the diagnosis of a low grade leiomyosarcoma should be made only with trepidation IMT Sarcoma Spindle cells Muscularis propria (detrusor) Involvement /- /- Myxoid /- /- Mitotic figures alpha-sma Cytokeratins (broad spectrum e.g. MNF116 or AE1/3 or low molecular weight e.g. CAM 5.2) [50% cases]/- -/ Sarcomatoid carcinoma /- /- /- -/ Differences: bladder spindle cell lesions IMT LMS Sarcomatoid carcinoma ALK-1 expression /- [<50% cases ve; some rhabdo ve] Nuclear Abnormal Large Prominent In-situ pleomorphism mitotic areas vascular carcinoma with figure(s) of background /- hypechromasia necrosis obvious epithelial areas - - - - /- /- - - - - - -/ CK5/6 34BE12 p63 - - - /- /- - /- - -/ -/ /- [27% [25% [50% ve]* ve]* ve]* *Westfall et al. Am J Surg Pathol 2009;33:99-105 [23% focal ve]* Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma Chang A. et al. Hum Pathol 2013; 44:1563-8. For sarcomatoid RCC, PAX8 ve in 69% (all were GATA3 ve) For sarcomatoid urothelial carcinoma of bladder and upper tract: GATA3 ve in 31% and 18% respectively; PAX8 ve in 18% and 4% respectively PAX8 was ve in 1/161 sarcoma cases (Ewings/PNET) All 161 sarcomas (various sites) were GATA3 negative 1/23 IMTs showed moderate GATA3 ve (all others and epithelioid AMLs were negative for GATA3 and PAX8) Neurofibroma of the urinary bladder Cheng L et al Cancer 1999;86:505-13 4 cases in Mayo Clinic registry from 1965-1990 Mean age was 17 (range 7-28) All 4 patients had stigmata of neurofibromatosis type 1 3 tumours were transmural showing diffuse and plexiform growth Bladder atony in 2 patients necessitated cystectomy 4 th case showed only diffuse mucosal involvement with Meisserian corpuscle formation Mean MiB-1 labelling index was 3.2% No malignant transformation with mean follow-up of 9.6 years Paraganglioma of bladder <0.05% of bladder tumours Other systemic paraganglioma symptoms in 15% cases May have a diffuse growth pattern that can be difficult to recognise as paraganglioma Can have a sclerosing pattern that mimics malignancy No reliable histological features for predicting malignancy (10% are malignant)

Malakoplakia McClure J J Pathol 1983;140:275-330 Myxoid cystitis with chordoid lymphocytes: another mimic of invasive urothelial carcinoma Hameed O Am J Surg Pathol 2010;34:1061-65 Polyclonal B lymphoid cells with epithelioid morphology arranged in a cohesive cord-like pattern in a myxoid background This was initially misinterpreted as recurrent invasive urothelial carcinoma (patient had previous history of invasive high grade urothelial carcinoma) The nature of atypical multinucleated stromal cells: a study of 37 cases from different sites (Pitt et al., 1993) Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains Tamas EF and Epstein JI Am J Surg Pathol 2007;31:390-397 10 cases from bladder Atypical stromal cells were associated with benign polyps, in peritumoural stroma or following radiotherapy No mitoses in any cases Mast cells often associated with atypical stromal cells Vimentin ve; desmin ve only in lower genital tract lesions (not elsewhere) Cam 5.2, alpha-sma, HHF-35, CD68 and S100 ve No myofibroblastic features by EM Probably represent a morphological variant of indigenous stromal cells Cytokeratins may be detected in myofibroblastic cells or even smooth muscle cells in the vicinity of a biopsy/tur site reaction and could be mistaken for residual tumour Morphology should be taken into account with concurrent use of alpha-sma and/or desmin h- caldesmon in interpretation All cases were Alk-1 -ve